These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24699210)

  • 21. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
    Pinto-Prades JL; Farreras V; de Bobadilla JF
    Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axiomatic foundations for cost-effectiveness analysis.
    Canning D
    Health Econ; 2013 Dec; 22(12):1405-16. PubMed ID: 23440955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scientific character of brain death argument and legal justice.
    Takase N
    Nihon Univ Comp Law; 1995; 12():103-9. PubMed ID: 12048738
    [No Abstract]   [Full Text] [Related]  

  • 24. Valuation of mortality risk attributable to climate change: investigating the effect of survey administration modes on a VSL.
    Sčasný M; Alberini A
    Int J Environ Res Public Health; 2012 Dec; 9(12):4760-81. PubMed ID: 23249861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capabilities as menus: a non-welfarist basis for QALY evaluation.
    Bleichrodt H; Quiggin J
    J Health Econ; 2013 Jan; 32(1):128-37. PubMed ID: 23202258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Priority setting in health care: disentangling risk aversion from inequality aversion.
    Echazu L; Nocetti D
    Health Econ; 2013 Jun; 22(6):730-40. PubMed ID: 22736580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fairness in cost-benefit analysis: A methodology for health technology assessment.
    Samson AL; Schokkaert E; Thébaut C; Dormont B; Fleurbaey M; Luchini S; Van de Voorde C
    Health Econ; 2018 Jan; 27(1):102-114. PubMed ID: 28620934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Publication selection and the income elasticity of the value of a statistical life.
    Doucouliagos H; Stanley TD; Viscusi WK
    J Health Econ; 2014 Jan; 33():67-75. PubMed ID: 24300998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Philosophical origins of the economic valuation of life.
    Robinson JC
    Milbank Q; 1986; 64(1):133-55. PubMed ID: 3084931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A universal preference for equality in health? Reasons to reconsider properties of applied social welfare functions.
    Mæstad O; Norheim OF
    Soc Sci Med; 2012 Nov; 75(10):1836-43. PubMed ID: 22939571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing risk preferences in cost-effectiveness analyses.
    Zivin JG; Bridges JF
    Appl Health Econ Health Policy; 2002; 1(3):135-9. PubMed ID: 14619264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Money or life?].
    Wyller TB
    Tidsskr Nor Laegeforen; 2003 Feb; 123(3):302. PubMed ID: 12640892
    [No Abstract]   [Full Text] [Related]  

  • 33. Valuation of morbidity and mortality risk reductions. Does context matter?
    Nielsen JS; Gyrd-Hansen D; Kjær T
    Accid Anal Prev; 2012 Sep; 48():246-53. PubMed ID: 22664687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [What type of welfare policy promotes health?: the puzzling interrelation of economic and health inequality].
    Hurrelmann K; Richter M; Rathmann K
    Gesundheitswesen; 2011 Jun; 73(6):335-43. PubMed ID: 21387217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equivalent income and fair evaluation of health care.
    Fleurbaey M; Luchini S; Muller C; Schokkaert E
    Health Econ; 2013 Jun; 22(6):711-29. PubMed ID: 22767541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'.
    Richardson JR; Olsen JA
    Health Econ; 2006 Mar; 15(3):311-3; discussion 319-22. PubMed ID: 16389655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equity weights in the allocation of health care: the rank-dependent QALY model.
    Bleichrodt H; Diecidue E; Quiggin J
    J Health Econ; 2004 Jan; 23(1):157-71. PubMed ID: 15154692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Happiness and health: lessons--and questions--for public policy.
    Graham C
    Health Aff (Millwood); 2008; 27(1):72-87. PubMed ID: 18180481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Values Beyond "Health" in Budget-Constrained Healthcare Systems.
    Phelps CE
    Value Health; 2024 Jul; 27(7):830-836. PubMed ID: 38401798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of real options on willingness to pay for mortality risk reductions.
    Krüger NA; Svensson M
    J Health Econ; 2009 May; 28(3):563-9. PubMed ID: 19261344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.